Prime Medicine CEO eyes CAR-T therapy for autoimmune diseases.

Prime Medicine is considering developing cell therapies for autoimmune diseases and may seek a partner for cancer cell therapies. The biotech would join a growing list of groups creating CAR-T therapies for autoimmune conditions like lupus, which were first developed for cancer and have been transformative for patients who can access them.